APA Alıntı

(2014). Correction for Chatzigeorgiou et al., Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. National Academy of Sciences.

Chicago Stili Alıntı

Correction for Chatzigeorgiou Et Al., Blocking CD40-TRAF6 Signaling Is a Therapeutic Target in Obesity-associated Insulin Resistance. National Academy of Sciences, 2014.

MLA Alıntı

Correction for Chatzigeorgiou Et Al., Blocking CD40-TRAF6 Signaling Is a Therapeutic Target in Obesity-associated Insulin Resistance. National Academy of Sciences, 2014.